IP Verse

Compositions And Methods Of Treating Tumors - EP3034093

The patent EP3034093 was granted to The Trustees OF The University OF Pennsylvania on Mar 13, 2019. The application was originally filed on Mar 4, 1999 under application number EP15183218A. The patent is currently recorded with a legal status of "Revoked".

EP3034093

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Application Number
EP15183218A
Filing Date
Mar 4, 1999
Status
Revoked
Mar 25, 2022
Grant Date
Mar 13, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

F HOFFMANN LA ROCHEDec 13, 2019VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE

Patent Citations (30) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS19940257783
DESCRIPTIONUS19970737269
DESCRIPTIONWO1995US07157
DESCRIPTIONWO1996US10245
DESCRIPTIONUS4235871
DESCRIPTIONUS4241046
DESCRIPTIONUS4394448
DESCRIPTIONUS5108921
DESCRIPTIONUS5470571
DESCRIPTIONUS5663144
DESCRIPTIONUS5677171
DESCRIPTIONUS5703055
DESCRIPTIONUS5705157
DESCRIPTIONUS5707618
DESCRIPTIONUS5756283
OPPOSITIONEP1058562
OPPOSITIONEP1745799
OPPOSITIONEP3034093
OPPOSITIONUS5470571
OPPOSITIONUS5677171
OPPOSITIONUS5705157
OPPOSITIONWO9802540
OPPOSITIONWO9817797
OPPOSITIONWO9818489
OPPOSITIONWO9944645
OPPOSITIONWO9960023
SEARCHUS5705157
SEARCHWO8906692
SEARCHWO9422478
SEARCHWO9634617

Non-Patent Literature (NPL) Citations (174) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- AKIYAMA ET AL., SCIENCE, (1986), vol. 232, page 1644
DESCRIPTION- ALROY ET AL., FEBS LETT., (1997), vol. 410, pages 83 - 86
DESCRIPTION- BARGMANN ET AL., CELL, (1986), vol. 45, page 649
DESCRIPTION- BARGMANN ET AL., EMBO, (1988), vol. 7, page 2043
DESCRIPTION- BARGMANN ET AL., NATURE, (1986), vol. 319, page 226
DESCRIPTION- BARGMANN ET AL., NATURE, (1986), vol. 319, pages 226 - 230
DESCRIPTION- BARGMANN ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, page 5394
DESCRIPTION- B. CULLEN, METH. ENZYMOL., (1987), vol. 152, pages 684 - 704
DESCRIPTION- BONI-SCHNETZLER ET AL., J BIOL. CHEM., (1988), vol. 263, page 6822
DESCRIPTION- BORGELT ET AL., "The palliation of brain metastases: Final results of the first two studies of the Radiation Therapy Oncology Group", INT J RADIAT ONCOL BIOL PHYS, (1980), vol. 6, pages 1 - 9, XP026837859
DESCRIPTION- BOSHART ET AL., CELL, (1985), vol. 41, pages 521 - 530
DESCRIPTION- BRIDGE; KETNER, J. VIROL., (198902), vol. 632, no. 2, pages 631 - 638
DESCRIPTION- C.A. LAUGHLIN ET AL., GENE, (1983), vol. 23, pages 65 - 73
DESCRIPTION- CALLAGHAN ET AL., ONCOGENE, (1993), vol. 8, pages 2939 - 2948
DESCRIPTION- CARRAWAY ET AL., CELL, (1994), vol. 78, pages 5 - 8
DESCRIPTION- CARTER ET AL., CRIT REV ONCOGENESIS, (1994), vol. 5, pages 389 - 428
DESCRIPTION- CAVENEE, W.K., CANCER, (1992), vol. 70, pages 1788 - 93
DESCRIPTION- CHAZIN ET AL., ONCOGENE, (1992), vol. 7, page 1859
DESCRIPTION- CHEN ET AL., CELL, (1989), vol. 59, page 33
DESCRIPTION- CHOU ET AL., J BIOL. CHEM., (1987), vol. 262, page 1842
DESCRIPTION- CONNELLY ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, page 6054
DESCRIPTION- COOPER ET AL., PROC. NATL. ACAD SCI. USA, (1988), vol. 85, page 4232
DESCRIPTION- DANIEL ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, page 2084
DESCRIPTION- DIFIORE ET AL., CELL, (1987), vol. 51, page 1063
DESCRIPTION- DIFIORE ET AL., SCIENCE, (1987), vol. 237, page 178
DESCRIPTION- DIMARCO ET AL., MOL. CELL. BIOL., (1990), vol. 10, page 3247
DESCRIPTION- DOBASHI ET AL., PROC. NATL. ACAD. SCI. USA, (1991), vol. 88, page 8582
DESCRIPTION- DOUGALL ET AL., J CELL. BIOCHEM., (1993), vol. 53, page 61
DESCRIPTION- DREBIN ET AL., CELL, (1985), vol. 41, page 695
DESCRIPTION- EKSTRAND ET AL., PROC. NATL. ACAD SCI., (1992), vol. 89, pages 4309 - 4313
DESCRIPTION- ENGELHARDT ET AL., HUM. GENE THER., (199410), vol. 5, pages 1217 - 1229
DESCRIPTION- ENGELHARDT ET AL., HUM GENE THER, (1994), vol. 5, pages 1217 - 1229
DESCRIPTION- ENGELHARDT ET AL., HUM. GENE THER., (1994), vol. 5, pages 1217 - 1229
DESCRIPTION- FELDER ET AL., CELL, (1990), vol. 61, page 623
DESCRIPTION- GAULTON ET AL., J 1MMUNOL, (1986), vol. 7, page 2470
DESCRIPTION- GAULTON ET AL., J IMMUNOL., (1986), vol. 7, page 2470
DESCRIPTION- GOLDMAN ET AL., BIOCHEMISTRY, (1990), vol. 29, page 11024
DESCRIPTION- GOLDMAN ET AL., HUM. GENE THER., (199507), vol. 6, pages 839 - 851
DESCRIPTION- GONNAN ET AL., J CELL. BIOCHEM., (1988), vol. 12A, page C219
DESCRIPTION- HALEY ET AL., ONCOGENE, (1989), vol. 4, pages 273 - 283
DESCRIPTION- HONEGGER ET AL., CELL, (1987), vol. 51, page 199
DESCRIPTION- HONEGGER ET AL., J. CELL BIOL., (1990), vol. 110, page 1541
DESCRIPTION- HONEGGER ET AL., MOL. CELL. BIOL., (1990), vol. 10, page 4035
DESCRIPTION- HUMPHREY ET AL., PROC. NATL. ACAD SCI., (1990), vol. 87, pages 4207 - 4211
DESCRIPTION- HUNG ET AL., PROC. NATL. ACAD SCI. USA, (1989), vol. 86, page 2545
DESCRIPTION- JAMES ET AL., CANCER RES., (1988), vol. 48, pages 5546 - 5551
DESCRIPTION- J.M. WILSON ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 3014 - 3018
DESCRIPTION- KASHLES ET AL., MOI. CELL. BIOL., (1991), vol. 11, page 1454
DESCRIPTION- KASHLES ET AL., MOL. CELL BIOL., (1991), vol. 11, page 1454
DESCRIPTION- KASHLES ET AL., MOL. CELL. BIOL., (1991), vol. 11, page 1454
DESCRIPTION- KERN ET AL., CANCER RES., (1990), vol. 50, page 5184
DESCRIPTION- KING ET AL., EMBO J, (1988), vol. 7, page 1647
DESCRIPTION- KIYOKAWA ET AL., PROC. NATL. ACAD. SCI., (1995), vol. 92, pages 1092 - 1096
DESCRIPTION- K. KOZARSKY ET AL., SOM. CELL MOL. GENET., (1993), vol. 19, no. 5, pages 449 - 458
DESCRIPTION- KOKAI ET AL., CELL, (1989), vol. 58, page 287
DESCRIPTION- KOKAI ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, page 8498
DESCRIPTION- KOKAI ET AL., PROC. NATL. ACAD SCI. USA, (1988), vol. 84, page 8498
DESCRIPTION- KOKAI ET AL., PROC. NATL. ACAD SCI. USA, (1988), vol. 85, page 5389
DESCRIPTION- KOMILOVA ET AL., ONCOGENE, (1992), vol. 7, page 511
DESCRIPTION- KOZARSKY ET AL., SOMATIC CELL AND MOLECULAR GENETICS, (1993), vol. 19, no. 5, pages 449 - 458
DESCRIPTION- KRAUS, M. H. ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 9193 - 9197
DESCRIPTION- LAEMMLI, NATURE, (1970), vol. 227, page 680
DESCRIPTION- LOFTS ET AL., ONCOGENE, (1993), vol. 8, pages 2813 - 2820
DESCRIPTION- MALDEN ET AL., CANCER RES., (1988), vol. 48, pages 2711 - 2714
DESCRIPTION- MCCLAIN ET AL., J. BIOL. CHEM., (1987), vol. 262, page 14663
DESCRIPTION- M.G. PETERSON ET AL., EUR. J. BIOCHEM., (1988), vol. 174, pages 417 - 424
DESCRIPTION- MOLLER ET AL., FEBS LEU., (1985), vol. 186, page 1
DESCRIPTION- MOLLER, FEBS LETT., (1985), vol. 186, page I
DESCRIPTION- MORI ET AL., LAB. INVEST, (1989), vol. 61, page 93
DESCRIPTION- NISHIKAWA ET AL., PROC. NATL. ACAD SCI., (1994), vol. 91, pages 7727 - 7731
DESCRIPTION- PAPEWALLS ET AL., NUCLEIC ACIDS RES., (1991), vol. 19, pages 5452 - 5452
DESCRIPTION- PINKAS-KRAMARSKI, ONCOGENE, (1997), vol. 15, pages 2803 - 2815
DESCRIPTION- PLOWMAN, G. D., PROC. NATL. ACA . SCI. USA, (1993), vol. 90, pages 1746 - 1750
DESCRIPTION- PRESS ET AL., ONCOGENE, (1990), vol. 5, page 953
DESCRIPTION- PRUSS ET AL., PROC. NATL. ACAD. SCI. USA, (1977), vol. 74, page 3918
DESCRIPTION- QIAN ET AL., PROC. NATL. A CAD SCI. USA, (1992), vol. 89, page 1330
DESCRIPTION- QIAN ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, page 1330
DESCRIPTION- QIAN ET AL., PROC. NATL. ACAD SCI. USA, (1994), vol. 91, page 1500
DESCRIPTION- QIAN ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, page 1500
DESCRIPTION- QIAN, O'ROURKE; ZHAO, GREENE, ONCOGENE, (1996), vol. 13, pages 2149 - 2157
DESCRIPTION- REMINGTON'S PHARMACEUTICAL SCIENCES
DESCRIPTION- RIESE ET AL., MOL. CELL. BIOL., (1995), vol. 15, pages 5770 - 5776
DESCRIPTION- RUSSELL ET AL., J. BIOL. CHEM., (1987), vol. 262, page 11833
DESCRIPTION- SAMULSKI ET AL., J. VIROL., (1987), vol. 61, pages 3096 - 3101
DESCRIPTION- SAMULSKI ET AL., J. VIROL., (1989), vol. 63, pages 3822 - 3828
DESCRIPTION- SCHECHTER, A. L. ET AL., NATURE, (1984), vol. 312, pages 513 - 516
DESCRIPTION- SCHECHTER ET AL., NATURE, (1984), vol. 312, page 513
DESCRIPTION- SCHLEGEL ET AL., INT J CANCER, (1994), vol. 56, pages 72 - 77
DESCRIPTION- SCOTT ET AL., MOL. CELL. BIOL., (1993), vol. 13, page 2247
DESCRIPTION- SIMPSON W.J. ET AL., "Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforms: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials", INT J RADIAT ONCOL BIOL PHYS, (1993), vol. 26, pages 239 - 244, XP026848892
DESCRIPTION- SLAMON ET AL., SCIENCE, (1989), vol. 244, page 707
DESCRIPTION- SLAMON, SCIENCE, (1987), vol. 235, page 177
DESCRIPTION- SOUTHERN ET AL., J. MOL. APPL. GENET., (1982), vol. 1, page 327
DESCRIPTION- SPIVAK-KROIZMAN ET AL., I BIOL. CHEM., (1992), vol. 267, page 8056
DESCRIPTION- SPIVAK-KROIZMAN ET AL., J BIOL. CHEM., (1992), vol. 267, page 8056
DESCRIPTION- STEM ET AL., MOL. CELL. BIOL., (1988), vol. 8, page 3969
DESCRIPTION- STERNBERG ET AL., FEBS LETT., (1984), vol. 175, page 387
DESCRIPTION- STERNBERG ET AL., FEBS LEU., (1984), vol. 175, page 387
DESCRIPTION- SUGAWA ET AL., PROC. NATL. ACAD SCI., (1990), vol. 87, pages 8602 - 8606
DESCRIPTION- SURDEN ET AL., NEURON, (1997), vol. 18, pages 847 - 855
DESCRIPTION- TAKEBE ET AL., MOL. CELL. BIOL., (1988), vol. 8, page 466
DESCRIPTION- T.A. KOST ET AL., NUCL. ACIDS RES., (1983), vol. 11, no. 23, page 8287
DESCRIPTION- TZAHAR ET AL., EMBO J., (1997), vol. 16, pages 4938 - 4950
DESCRIPTION- ULLRICH ET AL., NATURE, (1984), vol. 309, pages 418 - 425
DESCRIPTION- WADA ET AL., CELL, (1990), vol. 61, page 1339
DESCRIPTION- WEINBERG; KETNER, PROC. NATL. ACAD. SCI., USA, (1983), vol. 80, no. 17, pages 5383 - 5386
DESCRIPTION- WEINER ET AL., NATURE, (1989), vol. 339, page 230
DESCRIPTION- WEINER ET AL., ONCOGENE, (1989), vol. 4, page 1175
DESCRIPTION- WIERENGA ET AL., NATURE, (1983), vol. 302, page 842
DESCRIPTION- WILLIAMS ET AL., PATHOBIOL., (1991), vol. 59, page 46
DESCRIPTION- WONG ET AL., PROC. NATL. ACAD.SCI., (1987), vol. 84, pages 6899 - 6903
DESCRIPTION- WONG ET AL., PROC. NATL. ACAD SCI., (1992), vol. 89, pages 2965 - 2969
DESCRIPTION- YAMAMOTO ET AL., NATURE, (1986), vol. 319, page 230
DESCRIPTION- YAMAMOTO ET AL., NATURE, (1986), vol. 319, pages 230 - 234
DESCRIPTION- YAMAMOTO, T. ET AL., NATURE, (1986), vol. 319, pages 230 - 234
DESCRIPTION- YAMAZAKI ET AL., JPN. J CANCER RES., (1990), vol. 81, pages 773 - 779
DESCRIPTION- ZICK ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1984), vol. 119, page 6
EXAMINATION- O'ROURKE D M ET AL, "Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.", IMMUNOLOGIC RESEARCH 1998, (1998), vol. 17, no. 1-2, ISSN 0257-277X, pages 179 - 189
EXAMINATION- O'ROURKE D M ET AL, "Principles of receptor-based inhibition of erbB family receptor kinases: prospects for new therapies for human cancers.", PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS MAY 1997, (199705), vol. 109, no. 3, ISSN 1081-650X, pages 209 - 219
EXAMINATION- WADA T ET AL, "Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.", ONCOGENE APR 1990, (199004), vol. 5, no. 4, ISSN 0950-9232, pages 489 - 495
OPPOSITION- anonymous, "lmClone Systems Incorporated Reports Data on its Cancer Therapeutic, C225, at American Society of Clinical Oncology Meeting", lmClone Systems Incorporated - Press release, (19980518), XP055300730
OPPOSITION- "Are there risks involved?", NATIONAL CANCER INSTITUTE, Radiation Therapy and You: A Guide to Self-Help During Treatment, Diane Pub Co, (19930000), pages 5 - 6, 17-21, XP055663802
OPPOSITION- BALABAN et al., "The Effect of Ionizing Radiation on Signal Transduction: Antibodies to EGF Receptor Sensitize A431 Cells to Radiation", Biochemica et Biophysica Acta, (19960000), vol. 1314, pages 147 - 156, XP002755104
OPPOSITION- BRADY et al., "Malignant Astrocytomas Treated with Iodine-125 Labeled Monoclonal Antibody 425 Against Epidermal Growth Factor Receptor: A Phase II Trial", Int. J. Radiation Oncology Biol. Phys., (19910000), vol. 22, pages 225 - 230, XP026844035
OPPOSITION- BRADY L. W. et al., "319: Radioimmunotherapy of Human Gliomas using 1-125 Labeled Monoclonal Antibody to Epidermal Growth Factor Receptor", Proceedings of ASCO, (19880307), page 83, XP0055299102
OPPOSITION- CRAVEN et al., "Expression of c-erbB-2 gene in Human Head and Neck Carcinoma", Anticancer Research, vol. 12, no. 6B, pages 2273 - 2276, XP055299107
OPPOSITION- DE SANTES et al., "Radiolabeled Antibody Targeting of the HER-2/neu Oncoprotein", Cancer Research, (19920401), vol. 52, no. 7, pages 1916 - 1923, XP002914169
OPPOSITION- EZEKIEL M. P. et al., "Phase I Study of Anti-Epidermal Growth Factor Receptor (EGFR) Antibody C225 in Combination with Irradiation in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)", Proceedings 34th Annual Meeting of ASCO, (19980516), vol. 17, page 395a, XP055663809
OPPOSITION- GILL et al., "Monoclonal Anti-epidermal Growth Factor Receptor Antibodies Which Are Inhibitors of Epidermal Growth Factor Binding and Antagonists of Epidermal Growth Factor-stimulated Tyrosine Protein Kinase Activity", J. Biol. Chem, (19840625), vol. 259, no. 12, pages 7755 - 7760, XP055663827
OPPOSITION- HUANG et al., "Epidermal Growth Factor Receptor Blockade with C225 Modulates Proliferation, Apoptosis, and Radiosensitivity in Squamous Cell Carcinomas of the Head and Neck", Cancer Res., (19990000), vol. 59, pages 1935 - 1940, XP002907294
OPPOSITION- HUANG S. et al., "Effects of Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 (m225) on proliferation, apoptosis and radiosensitivity in Human Squamous Cell Carcinomas (SCC) of the Head and Neck (H&N)", PROCEEDINGS 89th Annual Meeting of the American Association for Cancer Research, (19980328), vol. 39, page 64, XP055663893
OPPOSITION- IBRAHIM et al., "Expression of c-erbB Proto- Oncogene Family Members in Squamous Cell Carcinoma of the Head and Neck", Anticancer Research, (19970000), vol. 17, pages 4539 - 4546, XP055299718
OPPOSITION- MIYAMOTO et al., "Utilization of 125I Monoclonal Antibody in the Management of Primary Glioblastoma Multiforme", Radiation Oncology Investigations, (19950000), vol. 3, pages 126 - 132, XP055299121
OPPOSITION- O'ROURKE D. M. et al., "Principles of receptor-based inhibition of erbB family receptor kinases: Prospects for New Therapies for Human Cancers", Proceedings of the Association of American Physicians, (19970500), vol. 109, no. 3, pages 209 - 219, XP055663895
OPPOSITION- O'ROURKE et al., "Immunologic Approaches to Inhibiting Cell -Surface-Residing Oncoproteins in Human Tumors", Immunological Research, (19980200), vol. 17, no. 1&2, pages 179 - 189, XP055299727
OPPOSITION- PARISE et al., "Prognostic impact of p53, c-erbB2 and epidermal growth factor receptor on head and neck carcinoma", Sao Paolo Medical Journal, (20040000), vol. 122, no. 6, pages 264 - 268, XP055291134
OPPOSITION- PIETRAS et al., "Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer", Oncogene, (19940000), vol. 9, pages 1829 - 1838, XP009090251
OPPOSITION- PIETRAS R. J. et al., "Monoclonal Antibody to Her-2 Receptor Modulates DNA Repair and Radiation Sensitivity in Human Breast and Ovarian Cancer Cells", Proceedings of the American Association for Cancer Research 87: Abstract Number 4166, (19960420), vol. 37, page 607, XP055299714
OPPOSITION- PRESS et al., "Amplification and Overexpression of 1994 Her-2/neu in Carcinomas of the Salivary Gland: Correlation with Poor Prognosis", Cancer Research, vol. 54, pages 5675 - 5682, XP000877239
OPPOSITION- PREWETT et al., "The Biological Effect of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate Carcinoma", J. Immunotherapy, (19970000), vol. 19, no. 6, pages 419 - 427, XP002922660
OPPOSITION- QIAN et al., "Intermolecular Association and Trans- Phosphorylation of Different neu-Kinase Forms Permit SH2-dependent Signaling and Oncogenic Transformation", Oncogene, (19950000), vol. 10, no. 1, pages 211 - 219, XP000675567
OPPOSITION- REESE D. et al., "Effects of the 4D5 antibody on HER2/neu March 1996 heterodimerization with Other Claim I Receptors in Human Breast Cancer Cells", Proceedings 87th Annual Meeting of the American Association for Cancer Research, (19960420), vol. 37, no. 19960424, page 51, XP055299716
OPPOSITION- SALEH M. et al., "In Vitro and In Vivo Evaluation of the March 1996 Cytotoxicity of Radiation Combined with Chimeric Monoclonal Antibody to Epidermal Growth Factor Receptor", Proceedings 87th Annual Meeting of the American Association for Cancer Research, (19960420), vol. 37, page 612, XP001027768
OPPOSITION- STACKHOUSE M. A. ET AL, "Radiosensitization by an Anti-erbB-2 single chain antibody in human ovarian cancer xenografts", Proceedings88th Annual Meeting of the American Association for Cancer Research, (19970412), vol. 38, page 250, XP055300685
OPPOSITION- "Therapy", Bettelheim F. A. et al, INTRODUCTION TO GENERAL , ORGANIC & BIOCHEMISTRY. 4th ed., Saunders College Publishing, (19950000), pages 268 - 269, XP05663787
OPPOSITION- WEINSTEIN et al., "Evaluation of Her-2/NEU (C-erbB-2) Oncogene Expression in Whole Organ Sections of Supraglottic Squamous Cell Carcinoma", Ann. Otol. Rhinol. Laryngol., (19960000), vol. 105, pages 275 - 279, XP055299712
OPPOSITION- WIKSTRAND et al., "Cell Surface Localization and Density of the Tumor-Associated Variant of the Epidermal Growth Factor Receptor, EGFRvIII", Cancer Research, (19970000), vol. 57, pages 4130 - 4140, XP008109768
OPPOSITION- WOLLMAN et al., "Effect of Epidermal Growth Factor on the Growth and Radiation Sensitivity of Human Breast Cancer Cells In Vitro", Int. J. Radiation Oncology Biol. Phys., (19940000), vol. 30, no. 1, pages 91 - 98, XP026849127
OPPOSITION- SHARAFINSKI et al., "Epidermal Growth Factor Receptor Targeted Therapy of Squamous Cell Carcinoma of the Head and Neck", Head Neck, (20101026), vol. 32, no. 10, pages 1412 - 1421, XP055300809
OPPOSITION- DOUGALL et al., "Interaction of the Neu/pl85 and EGF Receptor Tyrosine Kinases: Implications for Cellular Transformation and Tumor Therapy", J. Cell . Biochem., (19930901), vol. 53, no. 1, doi:10.1002/jcb.240530108, pages 61 - 73, XP001009901
OPPOSITION- BEI et al., "Co-localization of multiple ErbB receptors in 2001 stratified epithelium of oral squamous cell carcinoma", J Pathol, (20011000), vol. 195, no. 3, pages 343 - 348, XP055663924
OPPOSITION- DENARDO S. J. et al., "Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma", CANCER, (19971215), vol. 80, no. 12 Suppl, pages 2583 - 2590, XP008068543
OPPOSITION- VAN GOG et al., "Perspectives of Combined Radioimmunotherapy and Anti-EGFR Antibody Therapy for the Treatment of Residual Head and Neck Cancer", Int. J. Cancer, (19980703), vol. 77, no. 1, pages 13 - 18, XP002405039
OPPOSITION- REESE et al., "HER-2/neu Signal Transduction in 1997 Human Breast and Ovarian Cancer", Stem Cells, (19970000), vol. 15, doi:10.1002/stem.150001, pages 1 - 8, XP055299722
OPPOSITION- SCHIER et al., "Isolation of High-Affinity Monomeric Human Anti-ErbB-2 Single Chain Fv Using Affinity- Driven Selection", J. Mol. Biol., (19960000), vol. 255, doi:10.1006/jmbi.1996.0004, pages 28 - 43, XP000953467
OPPOSITION- LIU H. et al, "Chapter 4: EGFR Inhibitors as Therapeutic Agents in Head and Neck Cancer", LIU H. et al, Burtness B. et al, Molecular Determinants of Head and Neck Cancer, Springer, (20140000), pages 55 - 90, ISBN 978-1-4614-8814-9, XP055663927
OPPOSITION- SCHWECHHEIMER et al., "Expression of Neu/c-erbB-2 in Human Brain Tumors", Human Pathology, (19940801), vol. 25, no. 8, doi:10.1016/0046-8177(94)90246-1, pages 772 - 780, XP026255208
OPPOSITION- GOLDKORN et al., "EGF Receptor Phosphorylation is Affected by Ionizing Radiation", Biochemica et Biophysica Acta, (19970000), vol. 1358, doi:10.1016/S0167-4889(97)00063-3, pages 289 - 299, XP004277704
OPPOSITION- HAYDEN et al., "Antibody Engineering", Current Opinion in Immunology, (199700401), vol. 9, no. 2, doi:10.1016/S0952-7915(97)80136-7, pages 201 - 212, XP004327252
OPPOSITION- O'ROURKE et al., "Inhibition of a naturally occurring EGFR oncoprotein by the pl85neu ectodomain: implications for subdomain contributions to receptor assembly", Oncogene, (19980305), vol. 16, no. 9, pages 1197 - 1207, XP003012737
OPPOSITION- MASUDA et al., "AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neu", Oncogene, (20061200), vol. 25, no. 59, pages 7740 - 7746, XP055663890
OPPOSITION- O'ROURKE et al., "Trans Receptor Inhibition of Human Glioblastoma Cells by erbB Family Ectodomains", PNAS, (19970000), vol. 94, no. 7, pages 3250 - 3225, XP002307919
OPPOSITION- BACA et al., "Antibody Humanization Using Monovalent Phage Display", J. Biol. Chem., (19970000), vol. 272, no. 16, doi:10.1074/jbc.272.16.10678, pages 10678 - 10684, XP002308888
OPPOSITION- FAN et al., "Therapeutic Application of Anti- Growth Factor Receptor Antibodies", Current Opinion in ' Oncology, (19980100), vol. 10, no. 1, doi:10.1097/00001622-199801000-00011, pages 67 - 73, XP055299724
OPPOSITION- ALAOUI-JAMALI et al., "The role of ERbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications", Biochem. Cell Biol., (19970101), vol. 75, no. 4, doi:10.1139/bcb-75-4-315, pages 315 - 325, XP002920837
OPPOSITION- WATERHOUSE et al., "Assessment of EGFR/Her2 dimerization by FRET-FILM utilizing Alexa-conjugated secondary antibodies in relation to targeted therapies in cancer", Oncotarget, (20110901), vol. 2, no. 9, pages 728 - 736, XP002683519
SEARCH- EZEKIEL M P, ET AL., "phase i study of anti-epidermal growth factor receptor (egfr) antibody c225 in combination with irradiation in patients with advanced squamous cell carcinoma of the ead and neck (SCCHN). (Abstract 1522).", ASCO, Philadelphia, PA, US, (19980415), XP002755103 [AP] 1-8 * the whole document *
SEARCH- KWOK T T ET AL, "DIFFERENCES IN EGF RELATED RADIOSENSITIZATION OF HUMAN SQUAMOUS CARCINOMA CELLS WITH HIGH AND LOW NUMBERS OF EGF RECEPTORS", BRITISH JOURNAL OF CANCER, (1991), vol. 64, no. 2, ISSN 0007-0920, pages 251 - 254, XP055255397 [A] 1-8 * the whole document *
SEARCH- QIAN X ET AL, "INHIBITION OF P185NEU KINASE ACTIVITY AND CELLULAR TRANSFORMATION BY CO-EXPRESSION OF A TRUNCATED NEU PROTEIN", ONCOGENE, BASINGSTOKE, HANTS, GB, (19961121), vol. 13, no. 10, ISSN 0950-9232, pages 2149 - 2157, XP000675188 [AD] 1-8 * the whole document *
SEARCH- WOLLMAN R ET AL, "Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro", INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, USA, vol. 30, no. 1, ISSN 0360-3016, (19940830), pages 91 - 98, (19940830), XP026849127 [A] 1-8 * the whole document *
SEARCH- Z. FAN ET AL., "Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.", CANCER RESEARCH, USA, (19931001), vol. 53, no. 19, pages 4637 - 4642, XP001096358 [A] 1-8 * abstract *
SEARCH- BALABAN N ET AL, "THE EFFECT OF IONIZING RADIATION ON SIGNAL TRANSDUCTION: ANTIBODIESTO EGF RECEPTOR SENSITIZE A431 CELLS TO RADIATION", BIOCHIMICA ET BIOPHYSICA ACTA, ELSEVIER, NL, (19960101), vol. 1314, no. 1/02, doi:10.1016/S0167-4889(96)00068-7, ISSN 0006-3002, pages 147 - 156, XP001055207 [A] 1-8 * the whole document *
SEARCH- J. BASELGA ET AL., "Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.", JOURNAL OF THE NATIONAL CANCER INSTITUTE, (19930818), vol. 85, no. 16, pages 1327 - 1333, XP001095922 [A] 1-8 * abstract *
SEARCH- F. CIARDIELLO ET AL., "Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A", JOURNAL OF THE NATIONAL CANCER INSTITUTE, (19961204), vol. 88, no. 23, pages 1770 - 1776, XP001205987 [A] 1-8 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents